• No results found

University of Groningen Clinical advances in musculoskeletal imaging: spondylodiscitis and pediatric oncology Kasalak, Ömer

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Clinical advances in musculoskeletal imaging: spondylodiscitis and pediatric oncology Kasalak, Ömer"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Clinical advances in musculoskeletal imaging: spondylodiscitis and pediatric oncology

Kasalak, Ömer

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Kasalak, Ö. (2019). Clinical advances in musculoskeletal imaging: spondylodiscitis and pediatric oncology. University of Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Clinical advances in

musculoskeletal imaging:

spondylodiscitis and pediatric oncology

(3)

Clinical advances in musculoskeletal imaging: spondylodiscitis and pediatric oncology Thesis, Groningen University, The Netherlands

© Ömer Kasalak, 2018

All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means without permission in writing from the author. The copyright of the articles that have been published or have been accepted for publication has been transferred to the respective journals.

ISBN/EAN: ...-..-...-....-.

Printed by: Gildeprint Drukkerijen B.V., Enschede Layout: Roy Sanders

(4)

Clinical advances in

musculoskeletal imaging:

spondylodiscitis and pediatric oncology

Proefschrift

ter verkrijging van de graad doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op woensdag 23 Januari 2019 om 14:30 uur

door

Ömer Kasalak

geboren op 18 april 1978 te Izmir

(5)

Promotor Prof. dr. R.A.J.O. Dierckx

Copromotores Dr. T.C. Kwee Dr. P.C. Jutte

Beoordelingscommissie Prof. dr. S.K. Bulstra Prof. dr. C. van Kuijck Prof. dr. K. Verstraete

Printing of this thesis was financially supported by: Bracco Imaging, Pfizer BV, Mermaid Medical BV, Bayer BV.

(6)
(7)
(8)

Contents

Chapter 1 General introduction 9

PART I: Spondylodiscitis

Chapter 2 CT-guided biopsy in suspected spondylodiscitis: microbiological yield, impact on antimicrobial treatment, and relationship with outcome

25

Chapter 3 Culture yield of repeat percutaneous image-guided biopsy after a negative initial biopsy in suspected spondylodiscitis: a systematic review

43

PART II: Pediatric oncology

Chapter 4 Diagnostic value of MRI signs in differentiating Ewing sarcoma from osteomyelitis

61

Chapter 5 CT-guided bone biopsies with indeterminate results in pediatric patients

79

Chapter 6 Primary tumor volume measurements in Ewing sarcoma: MRI inter- and intraobserver variability and comparison with FDG-PET

99

Chapter 7 Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?

117

Chapter 8 Surveillance MRI for the detection of locally recurrent Ewing sarcoma seems futile

129

Chapter 9 General discussion 143

Chapter 10 Summary 157

Nederlandse samenvatting 161

Chapter 11 Dankwoord 165

Curriculum vitae 169

(9)

Referenties

GERELATEERDE DOCUMENTEN

When an initial CT-guided biopsy remains negative, it is unclear whether empirical antibiotic therapy should be started, if a repeat (second) image-guided biopsy should be

One potential reason for the reported low culture yields is data contamination with spondylodiscitis mimickers (such as Modic type I degeneration, acute Schmorl node,

There was high risk of bias in the domain patient selection in seven studies [10-16], because only a minority of patients with initial negative biopsy cultures underwent second

The purpose of this study was therefore to investigate the diagnostic value of several potentially useful MRI signs in differentiating Ewing sarcoma from osteomyelitis in patients

The latter finding is completely in line with the fact that several benign CT features and a smaller biopsy sample length (which occurs more frequently in benign lesions because

The purpose of this study was therefore to determine the inter- and intraobserver agreement of simplified MRI-based primary tumor volume measurements in newly

We showed the potential of in silico FGmRNA profiling as screening tool to predict overexpression for the highly specific tumor target glypican 3, and for 59

We identified 14 clinical imaging studies with trastuzumab, which makes this the most frequently investigated therapeutic mAb in molecular imaging (Fig. Several lessons can be